These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 4541468)

  • 1. Tumor immunity to murine plasma cell tumors. II. Essential role of T lymphocytes in immune response.
    Rouse BT; Röllinghoff M; Warner NL
    Eur J Immunol; 1973 Apr; 3(4):218-24. PubMed ID: 4541468
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative in vitro studies on effector cell diversity in the cellular immune response to murine sarcoma virus (MSV)-induced tumors in mice.
    Plata F; Gomard E; Leclerc JC; Levy JP
    J Immunol; 1974 Apr; 112(4):1477-87. PubMed ID: 4360862
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro induction of tumor specific immunity: requirements for T lymphocytes and tumor growth inhibition in vivo.
    Röllinghoff M; Wagner H
    Eur J Immunol; 1973 Aug; 3(8):471-6. PubMed ID: 4543174
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the induction and expression of T cell-mediated immunity. II. Antiserum blocking of cell-mediated cytolysis.
    Bonavida B
    J Immunol; 1974 Apr; 112(4):1308-21. PubMed ID: 4592598
    [No Abstract]   [Full Text] [Related]  

  • 5. Reversal by peritoneal adherent cells of tumor cell suppression of T cell-mediated immunity.
    Ting CC; Rodrigues D
    J Immunol; 1979 Aug; 123(2):801-7. PubMed ID: 156764
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell-mediated antitumor immune reactions under syngeneic conditions.
    Leclerc JC; Senik A; Gomard E; Plata F; Levy JP
    Transplant Proc; 1973 Dec; 5(4):1431-4. PubMed ID: 4359721
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo studies of the role of cytotoxic T cells in tumor allograft immunity.
    Freedman LR; Cerottini JC; Brunner KT
    J Immunol; 1972 Dec; 109(6):1371-8. PubMed ID: 4538966
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of T, B and adherent cells in the in vitro immune response of TEPC-183-bearing mice.
    Patel M; Havas HF
    Immunology; 1982 May; 46(1):97-105. PubMed ID: 6978846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor immunity to murine plasma cell tumors. V. Genetic control of the in vitro cytotoxic T-cell response to plasma cell tumor-associated antigens of NZB mice.
    Burton RC; Warner NL
    J Natl Cancer Inst; 1980 Aug; 65(2):431-40. PubMed ID: 6967529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary cytotoxic tumor immune response induced in vitro.
    Röllinghoff M
    J Immunol; 1974 May; 112(5):1718-25. PubMed ID: 4544796
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of the murine major histocompatibility complex in macrophage-mediated cytolysis.
    Somers SD; Zwilling BS
    J Immunol; 1978 Dec; 121(6):2453-7. PubMed ID: 214499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of lymphoid cells from normal and immune mice by syngeneic BALB/c plasma cell tumors.
    Boyer PJ; Fahey JL
    J Immunol; 1976 Jan; 116(1):202-9. PubMed ID: 128571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of 125-I-iododeoxyuridine into target cells as an assay for cell immunity.
    Fish F; Yaakubovicz M; Witz IP
    J Natl Cancer Inst; 1974 Dec; 53(6):1743-7. PubMed ID: 4436870
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukemia virus-induced immunosuppression. X. Depression of T cell-mediated cytotoxicity after infection of mice with Friend leukemia virus.
    Mortensen RF; Ceglowski WS; Friedman H
    J Immunol; 1974 Jun; 112(6):2077-86. PubMed ID: 4207729
    [No Abstract]   [Full Text] [Related]  

  • 15. Secondary in vitro lymphocyte-proliferative responses to syngeneic plasma cell tumors.
    Boyer PJ; Fahey JL
    Cancer Res; 1976 Apr; 36(4):1492-8. PubMed ID: 1083290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated immunity to Friend virus-induced leukemia. III. Characteristics of secondary cell-mediated cytotoxic response.
    Ting CC; Kirchner H; Rodrigues D; Park JY; Herberman RB
    J Immunol; 1976 Jan; 116(1):244-52. PubMed ID: 54388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved.
    Cihak J; Ziegler HW; Kölsch E
    Immunology; 1981 May; 43(1):133-43. PubMed ID: 6265346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Destruction of experimental malignant melanoma by mediators of cellular immunity.
    Youdim S
    Cancer Res; 1977 Feb; 37(2):572-7. PubMed ID: 401681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor immunity to murine plasma cell tumours. Influence of responder genotype on the specificity of the immune response to plasmacytomas and T lymphomas.
    Burton RC; Warner NL
    Aust J Exp Biol Med Sci; 1978 Oct; 56(5):587-95. PubMed ID: 751633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressor cell activation by anti-thy 1.2 in NZB/WF1 mice.
    Klassen LW; Zarate A; Gelfand MC; Steinberg AD
    J Immunol; 1977 Dec; 119(6):2067-72. PubMed ID: 334981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.